Comparison between Invicta Diagnostic IPO and R. P. Multimetals IPO.
Invicta Diagnostic IPO is a SME Bookbuilding IPO proposed to list at NSE SME while R. P. Multimetals IPO is a SME Bookbuilding proposed to list at BSE SME.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Socradamus Capital Pvt.Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Invicta Diagnostic IPO is up to ₹26.71 Cr whereas the issue size of the R. P. Multimetals IPO is up to ₹0.00 Cr. The final issue price of Invicta Diagnostic IPO is ₹85.00 per share and of R. P. Multimetals IPO is .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹85.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 31,42,400 shares | 47,94,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.71 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 31,42,400 shares | 47,94,000 shares |
| Issue Size Total (Amount) | up to ₹26.71 Cr | up to ₹0.00 Cr |
Invicta Diagnostic IPO opens on Dec 01, 2025, while R. P. Multimetals IPO opens on . The closing date of Invicta Diagnostic IPO and R. P. Multimetals IPO is Dec 03, 2025, and , respectively.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | |
| Issue Open | Dec 01, 2025 | |
| Issue Close | Dec 03, 2025 | |
| Basis Of Allotment (Tentative) | Dec 04, 2025 | |
| Initiation of Refunds (Tentative) | Dec 05, 2025 | |
| Credit of Share (Tentative) | Dec 05, 2025 | |
| Listing date (Tentative) | Dec 08, 2025 | |
| Anchor Lockin End date 1 | Jan 02, 2026 | |
| Anchor Lockin End date 2 | Mar 03, 2026 |
Invicta Diagnostic IPO P/E ratio is 14.51, as compared to R. P. Multimetals IPO P/E ratio of .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)R.P.Multimetals Ltd.'s revenue decreased by 18% and profit after tax (PAT) rose by 36% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.52 | 86.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.69 | 63.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹106.86 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.28% | 21.83% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 42.00% | 13.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.26 | 1.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.25% | 21.83% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Invicta Diagnostic IPO Retail Individual Investors (RII) are offered 12,67,200 shares while in R. P. Multimetals IPO retail investors are offered 12,67,200 shares. Qualified Institutional Buyers (QIB) are offered 5,34,400 shares in Invicta Diagnostic IPO and 0 shares in R. P. Multimetals IPO.
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,98,400 shares | 0 shares |
| Market Maker Reservation | 1,66,400 shares | 2,53,000 shares |
| QIB | 5,34,400 shares | 0 shares |
| NII | 5,42,400 shares | 0 shares |
| RII | 12,67,200 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 31,42,400 shares | 0 shares |
Invicta Diagnostic IPO subscribed 4.27x in total, whereas R. P. Multimetals IPO subscribed .
| Invicta Diagnostic IPO | R. P. Multimetals IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 6.96x | |
| Big NII (times) | 7.30x | |
| Small NII (times) | 6.27x | |
| RII (times) | 3.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.27x |
